{"filing":{"accession_number":"0001213900-26-072674","cik":"0001839285","ticker":"HCTI","company_name":"Healthcare Triangle, Inc.","form":"8-K","filing_date":"2026-06-26","report_date":null,"primary_document":"ea0296054-8k_healthcare.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1839285/000121390026072674/ea0296054-8k_healthcare.htm"},"events":[{"id":14322,"run_id":12746,"accession_number":"0001213900-26-072674","anchor_item_number":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"summary":"The filing discloses two material acquisition-related transactions: (1) a Securities Exchange Agreement with SecureKloud Technologies Ltd. involving the issuance of 2,828,167 common shares as a make-whole settlement for previously issued Series B Preferred Stock that became economically worthless due to reverse stock splits; and (2) Amendment No. 1 to a Share Purchase Agreement for the acquisition of companies through Teyame AI Holdings Inc., involving issuance of $12 million in restricted common stock, preferred stock convertible into 7.74 million shares, and earnout provisions. Both transactions involve material equity issuances and are disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), indicating significant capital structure changes and acquisition activity.","company_name":"Healthcare Triangle, Inc.","ticker":"HCTI","filing_date":"2026-06-26","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":11712,"accession_number":"0001213900-26-072674","item_number":null,"item_title":null,"event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.85,"reasoning":"The filing discloses two material acquisition-related transactions: (1) a Securities Exchange Agreement with SecureKloud Technologies Ltd. involving the issuance of 2,828,167 common shares as a make-whole settlement for previously issued Series B Preferred Stock that became economically worthless due to reverse stock splits; and (2) Amendment No. 1 to a Share Purchase Agreement for the acquisition of companies through Teyame AI Holdings Inc., involving issuance of $12 million in restricted common stock, preferred stock convertible into 7.74 million shares, and earnout provisions. Both transactions involve material equity issuances and are disclosed under Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), indicating significant capital structure changes and acquisition activity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-06-26T20:47:02.365295+00:00","company_name":"Healthcare Triangle, Inc.","ticker":"HCTI","filing_date":"2026-06-26"}]}